It is unclear how NF1 could provide a protective prognostic effect in CDKN2Aint patients, but this dichotomous impact of NF1 on survival in CDKN2A stratified patients suggests that CDKN2A may significantly modulate NF1 activity in IDHwt glioblastoma patients. The gene discussed is NF1; the disease is glioblastoma.